CLINICAL_TRIALS
trial_result
· 2013-07-02
Clinical Trial Update: A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT [Phase 3]
Summary
Phase 3 SUPPoRT trial evaluating regimen tolerability in underrepresented populations for HIV infections. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Georgetown University | Conditions: Human Immunodeficiency Virus Infections | Phase 3 | Status: COMPLETED | Results posted: 2013-07-02